Safety and potency of BIV1‐CovIran inactivated vaccine candidate for SARS‐CoV‐2: A preclinical study A Abdoli, R Aalizadeh, H Aminianfar, Z Kianmehr, A Teimoori, E Azimi, ... Reviews in medical virology 32 (3), e2305, 2022 | 54 | 2022 |
Safety and potency of COVIran barekat inactivated vaccine candidate for SARS-CoV-2: a preclinical study A Abdoli, R Aalizadeh, H Aminianfar, Z Kianmehr, E Azimi, N Emamipour, ... bioRxiv, 2021.06. 10.447951, 2021 | 12 | 2021 |
Assessment of BIV1-CovIran inactivated vaccine–elicited neutralizing antibody against the emerging SARS-CoV-2 variants of concern M Salehi, H Hosseini, HR Jamshidi, H Jalili, P Tabarsi, M Mohraz, ... Clinical Microbiology and Infection 28 (6), 882. e1-882. e7, 2022 | 10 | 2022 |
Lyme disease and new molecular biological detection methods A Choopani, F Matoofi, A Karami, R Alizadeh Novel Clin Med 2 (1), 11-23, 2023 | 2 | 2023 |
EFFECT OF BRI2 BRICHOS DOMAIN ON THE α-SYNUCLEIN AGGREGATION N KARDANI, B DABIRMANESH, R AALIZADEH, K KHAJEH | | 2015 |
Effect of Bri2 BRICHOS domain on the α-synuclein aggregation B Dabirmanesh, R Aalizadeh, K Khajeh, N Kardani | | |